CLINICAL USEFULNESS OF [(18)F] FLUORO-2-DEOXY-D-GLUCOSE UPTAKE IN 178 HEAD-AND-NECK CANCER PATIENTS WITH NODAL METASTASIS TREATED WITH DEFINITIVE CHEMORADIOTHERAPY: CONSIDERATION OF ITS PROGNOSTIC VALUE AND ABILITY TO PROVIDE GUIDANCE FOR OPTIMAL SELECTION OF PATIENTS FOR PLANNED NECK DISSECTION

被引:30
作者
Inokuchi, Haruo [1 ]
Kodaira, Takeshi
Tachibana, Hiroyuki
Nakamura, Tatsuya [2 ]
Tomita, Natsuo
Nakahara, Rie
Takada, Akinori [2 ]
Mizoguchi, Nobutaka
Tamaki, Tsuneo [3 ]
Fuwa, Nobukazu [2 ]
机构
[1] Aichi Canc Ctr Hosp, Dept Radiat Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan
[2] So Tohoku Proton Ctr, Dept Radiat Oncol, Koriyama, Fukushima, Japan
[3] Nagoya PET Imaging Ctr, Dept Radiol, Aichi, Japan
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2011年 / 79卷 / 03期
关键词
Head-and-neck cancer; Fluoro-2-deoxy-D-glucose; Positron emission tomography; FDG-PET; Prognosis; Chemoradiotherapy; Planned neck dissection; SQUAMOUS-CELL CARCINOMA; POSITRON-EMISSION-TOMOGRAPHY; STANDARDIZED UPTAKE VALUE; LOCALLY ADVANCED HEAD; FDG-PET; F-18; FLUORODEOXYGLUCOSE; RADIATION-THERAPY; LUNG-CANCER; PHASE-II; PREDICTION;
D O I
10.1016/j.ijrobp.2009.11.034
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the clinical effectiveness of pretreatment [(18)F] fluoro-2-deoxy-D-glucose-positron emission tomography for head-and-neck squamous cell carcinoma patients with nodal metastasis treated with chemoradiotherapy. Methods and Materials: Between March 2002 and December 2006, 178 patients with head-and-neck squamous cell carcinoma and nodal metastasis underwent fluoro-2-deoxy-D-glucose positron emission tomography before chemoradiotherapy. Fluoro-2-deoxy-D-glucose uptake by both the primary lesion and the neck node was measured using the standard uptake value (SUV). The overall survival, disease-free survival, local control, nodal progression-free survival, and distant metastasis-free survival rates were calculated, and several prognostic factors were evaluated. Results: The patients with a nodal SUV >= 6.00 had a significantly lower 3-year disease-free survival rate than those with a lower SUV (44% vs. 69%, p =.004). On multivariate analysis, a high SUV of nodal disease also proved to be a significantly unfavorable factor for disease-free survival (p =.04, 95% confidence interval [CI], 1.02-3.23), nodal progression-free survival (p =.05; 95% CI, 1.00-4.15), and distant metastasis-free survival (p =.016; 95% CI, 1.25-8.92). Among the patients with a greater nodal SUV (>= 6.00), those treated with planned neck dissection had better nodal progression-free survival than those in the observation group (p =.04, hazard ratio, 2.36; 95% CI, 1.00-5.85). Conclusion: Among head-and-neck squamous cell carcinoma patients treated with chemoradiotherapy, the pretreatment SUV of nodal disease was one of the strongest prognostic factors and also provided important information for the selection of patients suitable for planned neck dissection. (C) 2011 Elsevier Inc.
引用
收藏
页码:747 / 755
页数:9
相关论文
共 22 条
[1]   Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer [J].
Adelstein, DJ ;
Li, Y ;
Adams, GL ;
Wagner, H ;
Kish, JA ;
Ensley, JF ;
Schuller, DE ;
Forastiere, AA .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (01) :92-98
[2]   Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose [J].
Allal, AS ;
Slosman, DO ;
Kebdani, T ;
Allaoua, M ;
Lehmann, W ;
Dulguerov, P .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (05) :1295-1300
[3]  
[Anonymous], 2007, Clin Adv Hematol Oncol, V5, P79
[4]   Epidermal growth factor receptor expression in pretreatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomized controlled trial [J].
Bentzen, SM ;
Atasoy, BM ;
Daley, FM ;
Dische, S ;
Richman, PI ;
Saunders, MI ;
Trott, KR ;
Wilson, GD .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (24) :5560-5567
[5]   Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck [J].
Bonner, JA ;
Harari, PM ;
Giralt, J ;
Azarnia, N ;
Shin, DM ;
Cohen, RB ;
Jones, CU ;
Sur, R ;
Raben, D ;
Jassem, J ;
Ove, R ;
Kies, MS ;
Baselga, J ;
Youssoufian, H ;
Amellal, N ;
Rowinsky, EK ;
Ang, KK .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) :567-578
[6]   Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: The role of standardized uptake value [J].
Chan, Sheng-Chieh ;
Chang, Joseph Tung-Chieh ;
Wang, Hung-Ming ;
Lin, Chien-Yu ;
Ng, Shu-Hang ;
Fan, Kang-Hsing ;
Chin, Shy-Chyi ;
Liao, Chua-Ta ;
Yen, Tzu-Chen .
ORAL ONCOLOGY, 2009, 45 (01) :52-58
[7]   Alternating chemoradiotherapy for nasopharyngeal cancer using cisplatin and 5-fluorouracil: a Preliminary report of phase II study [J].
Fuwa, N ;
Kano, M ;
Toita, T ;
Shikama, N ;
Kodaira, T ;
Matsumoto, A ;
Kamata, M ;
Furutani, K ;
Tatibana, H .
RADIOTHERAPY AND ONCOLOGY, 2001, 61 (03) :257-260
[8]   ARTERIAL CHEMORADIOTHERAPY FOR LOCALLY ADVANCED TONGUE CANCER: ANALYSIS OF RETROSPECTIVE STUDY OF THERAPEUTIC RESULTS IN 88 PATIENTS [J].
Fuwa, Nobukazu ;
Kodaira, Takesi ;
Furutani, Kazuhisa ;
Tachibana, Hiroyuki ;
Nakamura, Tatsuya ;
Nakahara, Rie ;
Tomoda, Takuya ;
Inokuti, Haruo ;
Daimon, Takashi .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (04) :1090-1100
[9]   Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study [J].
Fuwa, Nobukazu ;
Kodaira, Takesi ;
Furutani, Kazuhisa ;
Tachibana, Hiroyuki ;
Nakamura, Tatsuya ;
Daimon, Takasi .
ORAL ONCOLOGY, 2007, 43 (10) :1014-1020
[10]   The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival [J].
Kidd, Elizabeth A. ;
Siegel, Barry A. ;
Dehdashti, Farrokh ;
Grigsby, Perry W. .
CANCER, 2007, 110 (08) :1738-1744